Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Arcturus Therapeutics (ARCT) has a market cap of $0.29 billion USD. According to our data, Arcturus Therapeutics is ranked No.6561 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.29 B |
-37.64%
|
| Dec 31, 2024 | $0.46 B |
-46.18%
|
| Dec 29, 2023 | $0.85 B |
85.91%
|
| Dec 30, 2022 | $0.46 B |
-54.17%
|
| Dec 31, 2021 | $1.00 B |
-14.68%
|
| Dec 31, 2020 | $1.18 B |
299.08%
|
| Dec 31, 2019 | $0.29 B |
139.96%
|
| Dec 31, 2018 | $0.12 B |
-43.02%
|
| Dec 29, 2017 | $0.22 B |
-45.92%
|
| Dec 30, 2016 | $0.40 B |
-66.56%
|
| Dec 31, 2015 | $1.19 B |
68.36%
|
| Dec 31, 2014 | $0.71 B |
-79.28%
|
| Dec 31, 2013 | $3.41 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Moderna
MRNA
|
$10.14 B |
-0.001 M
|
USA
|
 BioNTech
BNTX
|
$23.80 B |
0.001 M
|
Germany
|
 Curevac
CVAC
|
$0.73 B |
0.000 M
|
Germany
|
 Telesis Bio
TBIO
|
$1.33 M |
0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
USA
|
 Arrowhead Pharmaceuticals
ARWR
|
$1.77 B |
-0.000 M
|
USA
|
 Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
USA
|
 Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
USA
|
 Beam Therapeutics
BEAM
|
$1.73 B |
0.000 M
|
USA
|
 CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
Switzerland
|
 Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
USA
|
| Market Cap | = | ARCT Stock Price | * | ARCT Shares Outstanding |
| = | $10.57 | * | 27.12 M | |
| = | $0.29 B |